New York State Common Retirement Fund Vaxart, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$0.6 - $1.41 $45,988 - $108,072	-76,647 Reduced 98.86%	882 $1,000
Q4 2022 Jan 30, 2023	BUY	$0.75 - $2.24 $24 - $71	32 Added 0.04%	77,529 $74,000
Q3 2022 Nov 08, 2022	BUY	$2.09 - $4.5 $392 - $846	188 Added 0.24%	77,497 $169,000
Q2 2022 Aug 04, 2022	SELL	$2.7 - $5.28 $445 - $871	-165 Reduced 0.21%	77,309 $271,000
Q1 2022 May 05, 2022	BUY	$4.29 - $6.64 $501 - $776	117 Added 0.15%	77,474 $390,000
Q4 2021 Feb 02, 2022	SELL	$5.77 - $7.96 $1,863 - $2,571	-323 Reduced 0.42%	77,357 $485,000
Q3 2021 Nov 02, 2021	SELL	$6.67 - $9.8 $166,303 - $244,343	-24,933 Reduced 24.3%	77,680 $618,000
Q2 2021 Aug 02, 2021	BUY	$5.06 - $10.78 $313,279 - $667,422	61,913 Added 152.12%	102,613 $769,000
Q2 2020 Aug 07, 2020	BUY	$1.68 - $8.85 $68,376 - $360,195	40,700 New	40,700 $360,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.